Cargando…
Transcription factor E3 renal cell carcinoma presenting as secondary hypertension
Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common prese...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487286/ https://www.ncbi.nlm.nih.gov/pubmed/37692137 http://dx.doi.org/10.1097/CU9.0000000000000108 |
_version_ | 1785103203326492672 |
---|---|
author | Mukendi, Alain Mwamba Mataruka, Gerald Tatenda Nadimpalli, Ramesh Kasapato, Tshisola Miji |
author_facet | Mukendi, Alain Mwamba Mataruka, Gerald Tatenda Nadimpalli, Ramesh Kasapato, Tshisola Miji |
author_sort | Mukendi, Alain Mwamba |
collection | PubMed |
description | Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common presenting symptoms being hematuria, pain, and abdominal mass, or paraneoplastic event. In conventional RCCs, hypertension is considered a risk factor and a possible paraneoplastic event, whereas, in translocation RCCs, prior exposure to cytotoxic chemotherapy is the only known risk factor, and hypertension as an isolated associated paraneoplastic event has never been reported. Interestingly, hypertension as the only presenting symptom in RCC is extremely rare. We report a case of transcription factor E3 positive RCC in a young adult presenting only with hypertension that normalized after radical nephrectomy. To the best of our knowledge, this is the first reported case of hypertension secondary to microphthalmia-associated transcription translocation RCC. |
format | Online Article Text |
id | pubmed-10487286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104872862023-09-09 Transcription factor E3 renal cell carcinoma presenting as secondary hypertension Mukendi, Alain Mwamba Mataruka, Gerald Tatenda Nadimpalli, Ramesh Kasapato, Tshisola Miji Curr Urol Special Topic: Advances in Renal Cell Carcinoma Therapy: Case Report Microphthalmia-associated transcription factor family (transcription factor E3 or transcription factor EB) translocation renal cell carcinomas (RCCs) are rare neoplasms. These renal neoplasms can be either asymptomatic and incidentally discovered on imaging or symptomatic, with the most common presenting symptoms being hematuria, pain, and abdominal mass, or paraneoplastic event. In conventional RCCs, hypertension is considered a risk factor and a possible paraneoplastic event, whereas, in translocation RCCs, prior exposure to cytotoxic chemotherapy is the only known risk factor, and hypertension as an isolated associated paraneoplastic event has never been reported. Interestingly, hypertension as the only presenting symptom in RCC is extremely rare. We report a case of transcription factor E3 positive RCC in a young adult presenting only with hypertension that normalized after radical nephrectomy. To the best of our knowledge, this is the first reported case of hypertension secondary to microphthalmia-associated transcription translocation RCC. Lippincott Williams & Wilkins 2023-03 2022-08-02 /pmc/articles/PMC10487286/ /pubmed/37692137 http://dx.doi.org/10.1097/CU9.0000000000000108 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Special Topic: Advances in Renal Cell Carcinoma Therapy: Case Report Mukendi, Alain Mwamba Mataruka, Gerald Tatenda Nadimpalli, Ramesh Kasapato, Tshisola Miji Transcription factor E3 renal cell carcinoma presenting as secondary hypertension |
title | Transcription factor E3 renal cell carcinoma presenting as secondary hypertension |
title_full | Transcription factor E3 renal cell carcinoma presenting as secondary hypertension |
title_fullStr | Transcription factor E3 renal cell carcinoma presenting as secondary hypertension |
title_full_unstemmed | Transcription factor E3 renal cell carcinoma presenting as secondary hypertension |
title_short | Transcription factor E3 renal cell carcinoma presenting as secondary hypertension |
title_sort | transcription factor e3 renal cell carcinoma presenting as secondary hypertension |
topic | Special Topic: Advances in Renal Cell Carcinoma Therapy: Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487286/ https://www.ncbi.nlm.nih.gov/pubmed/37692137 http://dx.doi.org/10.1097/CU9.0000000000000108 |
work_keys_str_mv | AT mukendialainmwamba transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension AT matarukageraldtatenda transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension AT nadimpalliramesh transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension AT kasapatotshisolamiji transcriptionfactore3renalcellcarcinomapresentingassecondaryhypertension |